These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 36577651)

  • 21. Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort.
    Zhao T; Nishi-Uchi T; Omata F; Takita M; Kawashima M; Nishikawa Y; Yamamoto C; Kobashi Y; Kawamura T; Shibuya K; Kazama J; Shineha R; Tsubokura M
    BMJ Open; 2022 Nov; 12(11):e065741. PubMed ID: 36351730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Lymphocyte Phenotypic Alterations on the Humoral Response to Vaccination Against SARS-COV-2 in Dialysis Patients.
    Lioulios G; Fylaktou A; Asouchidou D; Xochelli A; Nikolaidou V; Stai S; Christodoulou M; Giamalis P; Tsouchnikas I; Papagianni A; Stangou M
    Ann Lab Med; 2023 Sep; 43(5):451-460. PubMed ID: 37080746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired Humoral but Substantial Cellular Immune Response to Variants of Concern B1.1.7 and B.1.351 in Hemodialysis Patients after Vaccination with BNT162b2.
    Thieme CJ; Blazquez-Navarro A; Safi L; Kaliszczyk S; Paniskaki K; Neumann IE; Schmidt K; Stockhausen M; Hörstrup J; Cinkilic O; Flitsch-Kiefner L; Meister TL; Marheinecke C; Pfaender S; Steinmann E; Seibert FS; Stervbo U; Westhoff TH; Roch T; Babel N
    J Am Soc Nephrol; 2021 Nov; 32(11):2725-2727. PubMed ID: 34716240
    [No Abstract]   [Full Text] [Related]  

  • 24. Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis.
    Hernández-Porto M; García S; Delgado T; Rodriguez Y; Aguirre-Jaime A; Campos S; Hernández C; Lorenzo C; Lecuona M
    Int J Infect Dis; 2022 Sep; 122():327-331. PubMed ID: 35671949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing Antibody Activity Against the B.1.617.2 (delta) Variant Before and After a Third BNT162b2 Vaccine Dose in Hemodialysis Patients.
    Benning L; Klein K; Morath C; Bartenschlager M; Kim H; Buylaert M; Reineke M; Töllner M; Nusshag C; Kälble F; Reichel P; Schnitzler P; Zeier M; Süsal C; Bartenschlager R; Schaier M; Speer C
    Front Immunol; 2022; 13():840136. PubMed ID: 35309320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis.
    Garcia P; Han J; Montez-Rath ME; Sun S; Shang T; Parsonnet J; Chertow GM; Anand S; Schiller B; Abra G
    Clin J Am Soc Nephrol; 2022 Jul; 17(7):1036-1038. PubMed ID: 35383042
    [No Abstract]   [Full Text] [Related]  

  • 27. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients.
    Broseta JJ; Rodríguez-Espinosa D; Rodríguez N; Mosquera MDM; Marcos MÁ; Egri N; Pascal M; Soruco E; Bedini JL; Bayés B; Maduell F
    Am J Kidney Dis; 2021 Oct; 78(4):571-581. PubMed ID: 34174364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral Response and SARS-CoV-2 Infection Risk following the Third and Fourth Doses of the BNT162b2 Vaccine in Dialysis Patients.
    Einbinder Y; Perl J; Nacasch N; Bnaya A; Shavit L; Erez D; Shashar M; Halperin T; Grupper A; Benchetrit S; Wand O; Cohen-Hagai K
    Am J Nephrol; 2022; 53(7):586-590. PubMed ID: 35850101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral Immune Response to COVID-19 Vaccination in Hemodialysis Patients: A Retrospective, Observational Case-Control Pilot Study.
    Piscitani L; Del Pinto R; Basili A; Tunno M; Ferri C
    High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):163-167. PubMed ID: 34978702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.
    Hirai K; Shimotashiro M; Sonoda T; Okumura T; Ookawara S; Morishita Y
    Clin Exp Nephrol; 2022 Sep; 26(9):925-932. PubMed ID: 35426594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody Response to COVID-19 Vaccination in Patients Receiving Dialysis.
    Anand S; Montez-Rath ME; Han J; Garcia P; Cadden L; Hunsader P; Kerschmann R; Beyer P; Dittrich M; Block GA; Boyd SD; Parsonnet J; Chertow GM
    J Am Soc Nephrol; 2021 Oct; 32(10):2435-2438. PubMed ID: 34117129
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients.
    Tillmann FP; Still H; von Landenberg P
    Int Urol Nephrol; 2022 Aug; 54(8):1939-1945. PubMed ID: 34860338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of Humoral and Cellular Responses in Renal Transplant Recipients Receiving 3 Doses of SARS-CoV-2 mRNA Vaccine.
    Arias-Cabrales C; Folgueiras M; Faura A; Eguia J; Padilla E; Hurtado S; Ribera L; Echeverria-Esnal D; Pérez-Sáez MJ; Redondo-Pachón D; Burballa C; Buxeda A; Llinàs-Mallol L; Cao H; Barbosa F; Rovira X; Cima F; Pascual J; Crespo M
    Transplantation; 2023 Feb; 107(2):457-465. PubMed ID: 36584381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses to the SARS-CoV-2 vaccines in hemodialysis patients: Is inactivated vaccine effective?
    Murt A; Altiparmak MR; Yadigar S; Yalin SF; Ozbey D; Yildiz Z; Kocazeybek B; Pekpak M; Ataman MR
    Ther Apher Dial; 2022 Aug; 26(4):769-774. PubMed ID: 34741418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis.
    Karakizlis H; Nahrgang C; Strecker K; Chen J; Aly M; Slanina H; Schüttler CG; Esso I; Wolter M; Todorova D; Jessen S; Adamik A; Ronco C; Seeger W; Weimer R; Sester M; Birk HW; Husain-Syed F
    Clin Immunol; 2022 Mar; 236():108961. PubMed ID: 35227871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients.
    Mulhern JG; Fadia A; Patel R; Ficociello LH; Willetts J; Dahne-Steuber IA; Pollan MC; Mullon C; DeLisi J; Johnson C; Mysayphonh C; Kossmann RJ; Anger MS; Hymes JL
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1720-1722. PubMed ID: 34312162
    [No Abstract]   [Full Text] [Related]  

  • 37. Humoral response and breakthrough infections with SARS-CoV-2 B.1.617.2 variant in vaccinated maintenance hemodialysis patients.
    Wand O; Nacasch N; Fadeela A; Shashar M; Grupper A; Benchetrit S; Erez D; Shitrit P; Cohen-Hagai K
    J Nephrol; 2022 Jun; 35(5):1479-1487. PubMed ID: 35175577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
    Kolb T; Fischer S; Müller L; Lübke N; Hillebrandt J; Andrée M; Schmitz M; Schmidt C; Küçükköylü S; Koster L; Kittel M; Weiland L; Dreyling KW; Hetzel G; Adams O; Schaal H; Ivens K; Rump LC; Timm J; Stegbauer J
    Kidney360; 2021 Sep; 2(9):1491-1498. PubMed ID: 35373105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses.
    Cinkilic O; Anft M; Blazquez-Navarro A; Meister TL; Roch T; Stervbo U; Pfaender S; Westhoff TH; Babel N
    Kidney Int; 2022 Jun; 101(6):1287-1289. PubMed ID: 35301007
    [No Abstract]   [Full Text] [Related]  

  • 40. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
    Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K
    Front Immunol; 2021; 12():704773. PubMed ID: 34220867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.